Luka Milos
1 followers · 1 following · 283 views
on the atlas · 2
- The optimistic case for protein foundation model companies1 savers
- Where are all the trillion dollar biotechs? — lada nuzhna3 savers
highlights · 2
the average development costs from first toxicity dose to first human dose for a single compound was $6.5 million (2011$) with the costs ranging from as low as $100,000 to as high as $27 million.
The optimistic case for protein foundation model companiesyet there were 4 failed MSTN antibodies before Scholar Rock got apitegromab approved earlier this year (indication/trial design failure). The list goes on and on.
Where are all the trillion dollar biotechs? — lada nuzhna